
Fall 2023
By Colleen Sullivan
The Gastric Cancer Foundation gave $100,000 to support the research of Dana-Farber’s Nilay Sethi, MD, PhD, who is investigating treatments for gastric cancers with homologous recombination (HR) deficiencies that have proven effective in other types of HR-deficient cancers.
